Covid-19 roundup: Sanofi & Regeneron deliver disappointing news on IL-6; Alex Azar rumors are swirling at HHS
A popular theory for how to treat some of the worst symptoms of Covid-19 stumbled today.
Sanofi and Regeneron announced that a Phase II/III trial …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
